APA (7th ed.) Citation

Jenks, J. D., Mehta, S. R., Taplitz, R., Aslam, S., Reed, S. L., & Hoenigl, M. (2019). Point‐of‐care diagnosis of invasive aspergillosis in non‐neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus‐specific Lateral Flow Device test in bronchoalveolar lavage. Mycoses, 62(3), 230-236. https://doi.org/10.1111/myc.12881

Chicago Style (17th ed.) Citation

Jenks, Jeffrey D., Sanjay R. Mehta, Randy Taplitz, Saima Aslam, Sharon L. Reed, and Martin Hoenigl. "Point‐of‐care Diagnosis of Invasive Aspergillosis in Non‐neutropenic Patients: Aspergillus Galactomannan Lateral Flow Assay Versus Aspergillus‐specific Lateral Flow Device Test in Bronchoalveolar Lavage." Mycoses 62, no. 3 (2019): 230-236. https://doi.org/10.1111/myc.12881.

MLA (9th ed.) Citation

Jenks, Jeffrey D., et al. "Point‐of‐care Diagnosis of Invasive Aspergillosis in Non‐neutropenic Patients: Aspergillus Galactomannan Lateral Flow Assay Versus Aspergillus‐specific Lateral Flow Device Test in Bronchoalveolar Lavage." Mycoses, vol. 62, no. 3, 2019, pp. 230-236, https://doi.org/10.1111/myc.12881.